Censis Technologies and Cantel Medical Enter Into Partnership

To Develop Differentiated Endoscope Reprocessing Software Solution

Censis Technologies and Cantel Medical have entered into a new long-term partnership to combine Cantel’s leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.

The new enhanced, co-branded software solution will combine the CANEXIS™ Integrated Workflow Solution for Endoscopy from Cantel with Censis’ CensiTrac™ surgical asset management software to create the leading instrument reprocessing and scope tracking software available to the market. Leveraging Censis’ strengths in software development, cloud-based technology, and professional services and support with the leading position in endoscope reprocessing and infection prevention from Cantel, the combined solution will support endoscopy customers with best-in-class quality management tools, providing peace of mind and confidence that their facility is executing best practices to support patient safety and infection prevention.

This enhanced integrated workflow solution is a key tool in the fight to avoid the spread of infection, while helping to protect patients and reducing the economic burden on facilities, while also supporting improved efficiency and understanding of the use of critical medical devices in healthcare facilities. In today’s environment, efficiency and process consistency are increasingly critical to the day-to-day and long-term success of infection prevention, and this software application is an important resource for helping to ensure a consistent repeatable standard of care and process at each facility.

Healthcare-associated infections (HAIs) are a complex and persistent issue in healthcare facilities. Each year, approximately 1.7 million HAIs occur, and outbreaks also pose a severe economic burden to the health system, with the total direct, indirect, and nonmedical social costs of HAIs to hospitals ranging from US$96 billion to $147 billion.1

Randy Smith, CEO, Censis Technologies said, “The relationship with Cantel will expand Censis’ leadership in surgical asset management and tracking solutions by further introducing innovative SaaS-based technology for the reprocessing of endoscopes. We are excited that the combined efforts of these two organizations will provide our customers with opportunities to improve patient safety, workflow optimization, and analytics.”

“We are thrilled to be partnering with Censis on this critical endeavor,” said Michael Spicer, President, Medical Business Unit at Cantel. “At Cantel, we strive to ensure our Complete Circle of Protection includes best-in-class offerings for our customers and patients, and by partnering with Censis, we are taking the next step toward providing greater efficiency, protection, and analytics to allow our customers to maximize their practice workflow while providing solutions designed to improve the safety and protection of their patients.”

Within the United States, users of the current CANEXIS™ Software can look forward to robust coverage, including implementation, upgrades, and technical support, as their service is enhanced through the co-brand partnership.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version